Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/592234


Drug Eluting Stents – Technology & Market Forecast


Description: After a difficult year seeing global revenue for drug eluting stents declining to US3.9 billion globally from a peak of US$5.1 billion in 2005, the market for drug-coated stents is getting back on track.

Over publicized negative outcome results from a sub-group of clinical studies triggered a reduction in total percutaneous coronary intervention procedures as well as a decrease in penetration levels of drug eluting stents share of these procedures.

New studies emerging from European Society of Cardiology (ESC) and the Transcatheter Cardiovascular Therapeutics (TCT) conferences have re-asserted the underlying safety and efficacy of DES, and challenged earlier negative late stent thrombosis results.

As the dust settles, early positive trends in drug coated stents global sales are emerging and impressive new product launches are expected in the US market in 2008. Waning COURAGE impact combined with favorable media response to newer longer-term trial results are leading to better device prescription volumes in all geographical segments.

It provides a timely analysis of this market with profiles of leading participants and forecasts to the year 2015.

With Drug Eluting Stents - Technology & Market Forecast, you’ll be able to:

1. Understand current market dynamics, competitors positions and market shares.

2. Assess market size and growth potential for these combined drug devices.

3. Monitor the competition’s marketed and in-development products.

4. Identify emerging technologies and the companies behind them.

5. Assess market potential and have access to forecasts till 2015.

6. Leverage your own technology and brain storm new business opportunities.

7. Investigate mergers, acquisitions and licensing possibilities

Drug Eluting Stents - Technology & Market Forecast is targeted at busy senior executives in medical technology companies who are interested in developing an understanding of this highly dynamic evolving market.


Contents: 1. Executive Summary

2. State of the Science

2.1 Coronary Artery Disease (CAD)
2.1.1 Epidemiology
2.1.2 Diagnosis
2.1.3 Management
2.2 Medical Management
2.3 Coronary Artery Bypass & Graft (CABG)
2.4 Percutaneous Transluminal Coronary Angioplasty (PTCA)
2.5 Clinical Trials Update

3. State of the Technology

3.1 Procedure
3.2 Drug Eluting Stents Design
3.3 Surface Coating Technology
3.4 Drug Coated Stents Technology
3.5 Drug Eluting Stents Technology

4. State of the Market

4.1 Current Market Situation of Drug Eluting Stents
4.2 Global Market for Drug Eluting Stents
4.3 US Market for Drug Eluting Stents
4.4 European Market for Drug Eluting Stents
4.5 Japanese Market for Drug Eluting Stents

5. Leading Companies & Their Products

5.1 Abbott
5.2 Allvivo
5.3 Bay Street Medical
5.4 Biocompatibles
5.5 Biosensors International
5.6 Biotronik
5.7 Blue Medical
5.8 Boston Scientific
5.9 CardioTech
5.10 Cook Medical
5.11 Cordis - Johnson & Johnson
5.12 Devax
5.13 Endovasc
5.14 Goodman
5.15 Implant Sciences
5.16 InnoCore
5.17 Lombard Medical
5.18 Medtronic
5.19 OrbusNeich
5.20 Reva Medical
5.21 SonoTek
5.22 Sorin
5.23 SurModics
5.24 Terumo
5.25 Translumina
5.26 X-Cell Medical
5.27 Xtent

6. Market Forecast

6.1 The Opportunity
6.2 Market Potential
6.3 Market Forecast


List of Tables & Figures

1. Global Drug Eluting Stents Market (2002 - 2007)
2. North American Drug Eluting Stents Market (2002 - 2007)
3. European Drug Eluting Stents Market (2002 - 2007)
4. Japanese Drug Eluting Stents Market (2004 - 2007)
5. Percutaneous Coronary Intervention Trends
6. Drug Eluting Stents – Pharmacological Agents
7. Drug Eluting Stents - Products in Development and Near Commercialization
8. Leading Drug Eluting Stents on World Markets
9. Global Drug Eluting Stents Market Forecast (2008 - 2015)


Companies Mentioned Abbott Allvivo Bay Street Medical Biocompatibles Biosensors International Biotronik Blue Medical Boston Scientific CardioTech Cook Medical Cordis - Johnson & Johnson Devax Endovasc Goodman Implant Sciences InnoCore Lombard Medical Medtronic OrbusNeich Reva Medical SonoTek Sorin SurModics Terumo Translumina X-Cell Medical Xtent


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/592234

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 27/11/2009 03:50:23
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Drug Eluting Stents – Technology & Market Forecast
Web Address:
http://www.researchandmarkets.com/reports/592234
Office Code:
OC8HJNPOUMUXU

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €980.00
Electronic (PDF) - Site License €1,960.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 27/11/2009 03:50:23

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)